Soleno Therapeutics (SLNO) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.91
-0.8
-0.69
-0.58

Details

Expected EPS
-0.83
Actual EPS
-0.81
Surprise EPS
0.02
Surprise Percent
+2.41%

Description

Soleno Therapeutics (SLNO) has reported earnings of -0.81 per share for Q2 2023.

0 Comments

Share your thoughts